Concepts (270)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
China | 54 | 2024 | 2395 | 3.990 |
Why?
|
Health Expenditures | 23 | 2024 | 2389 | 2.570 |
Why?
|
Health Care Reform | 14 | 2024 | 1256 | 2.460 |
Why?
|
Delivery of Health Care | 20 | 2024 | 5366 | 1.990 |
Why?
|
Hospitals, Public | 6 | 2024 | 204 | 1.840 |
Why?
|
Private Sector | 5 | 2024 | 396 | 1.800 |
Why?
|
National Health Programs | 13 | 2017 | 442 | 1.710 |
Why?
|
Hospitals, County | 2 | 2022 | 18 | 1.580 |
Why?
|
Pharmacies | 2 | 2024 | 171 | 1.560 |
Why?
|
Insurance, Health | 15 | 2023 | 2517 | 1.550 |
Why?
|
Poverty | 9 | 2024 | 2720 | 1.440 |
Why?
|
Rural Health Services | 9 | 2016 | 394 | 1.400 |
Why?
|
Budgets | 2 | 2022 | 232 | 1.380 |
Why?
|
Financing, Government | 5 | 2022 | 473 | 1.380 |
Why?
|
Quality of Health Care | 16 | 2024 | 4310 | 1.250 |
Why?
|
Reimbursement, Incentive | 5 | 2021 | 541 | 1.190 |
Why?
|
Health Policy | 12 | 2024 | 2698 | 1.030 |
Why?
|
Economic Development | 2 | 2015 | 72 | 0.940 |
Why?
|
Drugs, Essential | 1 | 2024 | 71 | 0.900 |
Why?
|
Catastrophic Illness | 2 | 2022 | 60 | 0.890 |
Why?
|
Telemedicine | 4 | 2024 | 3109 | 0.830 |
Why?
|
Health Services | 5 | 2023 | 755 | 0.820 |
Why?
|
Fraud | 1 | 2023 | 66 | 0.810 |
Why?
|
Fee-for-Service Plans | 7 | 2024 | 713 | 0.800 |
Why?
|
Developing Countries | 4 | 2024 | 2913 | 0.800 |
Why?
|
Primary Health Care | 12 | 2023 | 4746 | 0.780 |
Why?
|
Professional Practice | 1 | 2023 | 314 | 0.750 |
Why?
|
Physicians | 6 | 2024 | 4598 | 0.750 |
Why?
|
Cities | 1 | 2023 | 543 | 0.720 |
Why?
|
Government Programs | 2 | 2022 | 278 | 0.700 |
Why?
|
Single-Payer System | 2 | 2017 | 35 | 0.680 |
Why?
|
Financing, Personal | 2 | 2022 | 310 | 0.670 |
Why?
|
India | 6 | 2024 | 2334 | 0.610 |
Why?
|
Hospital Administration | 1 | 2022 | 351 | 0.600 |
Why?
|
Social Sciences | 1 | 2017 | 40 | 0.580 |
Why?
|
Social Medicine | 1 | 2017 | 64 | 0.550 |
Why?
|
Health Services Accessibility | 10 | 2024 | 5520 | 0.540 |
Why?
|
Rural Population | 8 | 2022 | 2325 | 0.530 |
Why?
|
Long-Term Care | 1 | 2020 | 631 | 0.530 |
Why?
|
Pneumonia, Bacterial | 1 | 2019 | 320 | 0.520 |
Why?
|
Public Sector | 4 | 2024 | 266 | 0.510 |
Why?
|
Privatization | 2 | 2014 | 41 | 0.480 |
Why?
|
Capitation Fee | 2 | 2014 | 115 | 0.470 |
Why?
|
Patient Satisfaction | 4 | 2024 | 3488 | 0.460 |
Why?
|
Motivation | 4 | 2023 | 2020 | 0.460 |
Why?
|
Surgical Procedures, Operative | 2 | 2015 | 1932 | 0.440 |
Why?
|
Specialties, Surgical | 2 | 2015 | 391 | 0.440 |
Why?
|
Urban Population | 2 | 2020 | 2045 | 0.430 |
Why?
|
Insurance Coverage | 4 | 2012 | 1946 | 0.430 |
Why?
|
Cost Control | 1 | 2015 | 627 | 0.420 |
Why?
|
Humans | 82 | 2024 | 767991 | 0.410 |
Why?
|
Costs and Cost Analysis | 1 | 2018 | 1666 | 0.400 |
Why?
|
Internet | 1 | 2024 | 3110 | 0.400 |
Why?
|
Quality Indicators, Health Care | 4 | 2019 | 1805 | 0.400 |
Why?
|
Prospective Payment System | 2 | 2004 | 134 | 0.380 |
Why?
|
Health Care Costs | 3 | 2020 | 3239 | 0.360 |
Why?
|
Prescription Drugs | 1 | 2018 | 635 | 0.360 |
Why?
|
Patient Acceptance of Health Care | 5 | 2020 | 3231 | 0.350 |
Why?
|
Health Personnel | 4 | 2024 | 3385 | 0.320 |
Why?
|
Health Services Needs and Demand | 4 | 2015 | 1406 | 0.320 |
Why?
|
Taiwan | 6 | 2017 | 521 | 0.310 |
Why?
|
Health Facilities | 2 | 2024 | 578 | 0.310 |
Why?
|
Myocardial Infarction | 2 | 2019 | 11519 | 0.300 |
Why?
|
Smoking | 1 | 2024 | 9089 | 0.290 |
Why?
|
Insurance, Hospitalization | 2 | 2004 | 30 | 0.290 |
Why?
|
Periodicals as Topic | 1 | 2017 | 1465 | 0.270 |
Why?
|
Models, Econometric | 5 | 2008 | 215 | 0.270 |
Why?
|
Hospitals | 4 | 2022 | 3886 | 0.260 |
Why?
|
Qualitative Research | 3 | 2023 | 3140 | 0.260 |
Why?
|
Brain Ischemia | 1 | 2019 | 3007 | 0.250 |
Why?
|
Efficiency, Organizational | 3 | 2024 | 697 | 0.230 |
Why?
|
Hospitals, Private | 1 | 2004 | 67 | 0.230 |
Why?
|
Government | 2 | 2022 | 161 | 0.230 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2019 | 3251 | 0.230 |
Why?
|
Economic Competition | 2 | 2004 | 223 | 0.220 |
Why?
|
Hospital Charges | 1 | 2004 | 347 | 0.210 |
Why?
|
Economics, Hospital | 1 | 2024 | 208 | 0.190 |
Why?
|
Health Status | 4 | 2009 | 4092 | 0.190 |
Why?
|
Control Groups | 1 | 2021 | 107 | 0.190 |
Why?
|
Aging | 1 | 2020 | 8744 | 0.190 |
Why?
|
Factor Analysis, Statistical | 1 | 2024 | 1001 | 0.190 |
Why?
|
Trust | 2 | 2022 | 532 | 0.190 |
Why?
|
Multilevel Analysis | 1 | 2021 | 148 | 0.180 |
Why?
|
Social Justice | 2 | 2006 | 486 | 0.180 |
Why?
|
Residential Facilities | 1 | 2020 | 41 | 0.180 |
Why?
|
Clinical Competence | 1 | 2016 | 4857 | 0.180 |
Why?
|
Proto-Oncogene Proteins c-bcl-6 | 1 | 2021 | 190 | 0.180 |
Why?
|
Income | 4 | 2023 | 1878 | 0.170 |
Why?
|
Stroke | 2 | 2020 | 9755 | 0.170 |
Why?
|
Hospitalization | 2 | 2021 | 10840 | 0.170 |
Why?
|
Quality Improvement | 2 | 2021 | 3855 | 0.170 |
Why?
|
Family Characteristics | 2 | 2022 | 1003 | 0.160 |
Why?
|
Cross-Sectional Studies | 4 | 2022 | 26375 | 0.160 |
Why?
|
Mental Health | 2 | 2019 | 3275 | 0.160 |
Why?
|
Diffusion of Innovation | 1 | 2023 | 724 | 0.150 |
Why?
|
Tobacco Smoke Pollution | 1 | 2024 | 828 | 0.150 |
Why?
|
Fee Schedules | 1 | 1998 | 86 | 0.150 |
Why?
|
Reimbursement Mechanisms | 1 | 2024 | 670 | 0.150 |
Why?
|
Health Resources | 1 | 2024 | 950 | 0.150 |
Why?
|
Chronic Disease | 3 | 2023 | 9384 | 0.150 |
Why?
|
Sexually Transmitted Diseases | 1 | 2024 | 668 | 0.150 |
Why?
|
Drug Prescriptions | 3 | 2016 | 1667 | 0.150 |
Why?
|
Medicare Part B | 1 | 1998 | 116 | 0.140 |
Why?
|
Pharmaceutical Preparations | 2 | 2022 | 1086 | 0.140 |
Why?
|
School Health Services | 1 | 2001 | 388 | 0.140 |
Why?
|
Social Support | 2 | 2006 | 2193 | 0.140 |
Why?
|
Middle Aged | 20 | 2024 | 223422 | 0.140 |
Why?
|
Pilot Projects | 2 | 2024 | 8740 | 0.140 |
Why?
|
Forecasting | 2 | 2017 | 2945 | 0.140 |
Why?
|
Young Adult | 6 | 2024 | 60048 | 0.140 |
Why?
|
Ambulatory Care | 3 | 2022 | 2781 | 0.130 |
Why?
|
Health Education | 2 | 2019 | 1059 | 0.130 |
Why?
|
Male | 23 | 2024 | 364641 | 0.130 |
Why?
|
Pandemics | 3 | 2024 | 8748 | 0.120 |
Why?
|
Female | 24 | 2024 | 397113 | 0.120 |
Why?
|
Anti-Bacterial Agents | 1 | 2014 | 7470 | 0.120 |
Why?
|
Hospital Costs | 1 | 2001 | 957 | 0.120 |
Why?
|
Adult | 18 | 2024 | 223583 | 0.120 |
Why?
|
Disease Outbreaks | 1 | 2023 | 1761 | 0.110 |
Why?
|
Matched-Pair Analysis | 1 | 2014 | 285 | 0.110 |
Why?
|
Infant, Newborn | 2 | 2023 | 26420 | 0.110 |
Why?
|
Patient Preference | 1 | 2020 | 946 | 0.100 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2019 | 1243 | 0.100 |
Why?
|
Medical Informatics | 2 | 2017 | 743 | 0.100 |
Why?
|
Aged | 13 | 2021 | 171446 | 0.100 |
Why?
|
Healthcare Disparities | 3 | 2022 | 3414 | 0.100 |
Why?
|
Clinical Governance | 1 | 2012 | 7 | 0.100 |
Why?
|
Health Services Research | 3 | 2014 | 1815 | 0.100 |
Why?
|
Diabetes Complications | 1 | 2019 | 1319 | 0.100 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2019 | 1515 | 0.100 |
Why?
|
Disabled Persons | 1 | 2021 | 1210 | 0.100 |
Why?
|
Fees, Medical | 2 | 2004 | 111 | 0.100 |
Why?
|
Socioeconomic Factors | 8 | 2020 | 7851 | 0.100 |
Why?
|
History, 21st Century | 1 | 2017 | 1572 | 0.090 |
Why?
|
Insurance, Health, Reimbursement | 2 | 2008 | 388 | 0.090 |
Why?
|
Cost-Benefit Analysis | 2 | 2014 | 5536 | 0.090 |
Why?
|
Insurance Benefits | 2 | 2014 | 185 | 0.090 |
Why?
|
Perception | 1 | 2016 | 1209 | 0.080 |
Why?
|
Prevalence | 2 | 2024 | 15867 | 0.080 |
Why?
|
History, 20th Century | 1 | 2017 | 2766 | 0.080 |
Why?
|
Coronary Artery Bypass | 1 | 1998 | 2191 | 0.080 |
Why?
|
Myocardial Ischemia | 1 | 2020 | 2138 | 0.080 |
Why?
|
Insurance, Major Medical | 1 | 2008 | 12 | 0.080 |
Why?
|
Medical Indigency | 1 | 2008 | 63 | 0.080 |
Why?
|
Voluntary Programs | 1 | 2008 | 48 | 0.080 |
Why?
|
Medical Savings Accounts | 1 | 2008 | 34 | 0.080 |
Why?
|
Longitudinal Studies | 4 | 2017 | 14783 | 0.080 |
Why?
|
Neoplasm Proteins | 1 | 2021 | 3601 | 0.080 |
Why?
|
Unnecessary Procedures | 1 | 2011 | 412 | 0.080 |
Why?
|
Health Status Disparities | 1 | 2020 | 1885 | 0.070 |
Why?
|
Health Services Misuse | 1 | 2010 | 246 | 0.070 |
Why?
|
Child | 4 | 2023 | 80906 | 0.070 |
Why?
|
Inpatients | 1 | 2019 | 2570 | 0.070 |
Why?
|
Aspirin | 1 | 2019 | 3135 | 0.070 |
Why?
|
Cluster Analysis | 1 | 2014 | 2731 | 0.070 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2019 | 2764 | 0.070 |
Why?
|
Adolescent | 9 | 2024 | 89155 | 0.070 |
Why?
|
Community Health Centers | 1 | 2010 | 469 | 0.070 |
Why?
|
Insurance Selection Bias | 1 | 2006 | 69 | 0.060 |
Why?
|
Patient Discharge | 1 | 2019 | 3476 | 0.060 |
Why?
|
Anthropology, Cultural | 1 | 2005 | 103 | 0.060 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2021 | 3626 | 0.060 |
Why?
|
Private Practice | 1 | 2005 | 154 | 0.060 |
Why?
|
Urban Health Services | 1 | 2005 | 177 | 0.060 |
Why?
|
Anesthesia | 1 | 2015 | 1595 | 0.060 |
Why?
|
Insurance Pools | 1 | 2004 | 13 | 0.060 |
Why?
|
Evidence-Based Practice | 1 | 2008 | 500 | 0.060 |
Why?
|
Incidence | 1 | 2022 | 21532 | 0.060 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2019 | 3251 | 0.060 |
Why?
|
Community Networks | 1 | 2005 | 202 | 0.050 |
Why?
|
Social Responsibility | 1 | 2006 | 382 | 0.050 |
Why?
|
Physician-Patient Relations | 1 | 2016 | 3269 | 0.050 |
Why?
|
Models, Statistical | 1 | 2017 | 5107 | 0.050 |
Why?
|
Aged, 80 and over | 4 | 2019 | 59598 | 0.050 |
Why?
|
Health Care Sector | 1 | 2004 | 196 | 0.050 |
Why?
|
Hospitals, Urban | 1 | 2004 | 496 | 0.050 |
Why?
|
Life Expectancy | 1 | 2008 | 1248 | 0.050 |
Why?
|
Egypt | 1 | 2001 | 100 | 0.050 |
Why?
|
Tumor Stem Cell Assay | 1 | 2021 | 116 | 0.050 |
Why?
|
Radiation Chimera | 1 | 2021 | 216 | 0.050 |
Why?
|
Health Care Rationing | 1 | 2004 | 435 | 0.040 |
Why?
|
Diabetes Mellitus | 1 | 2019 | 5887 | 0.040 |
Why?
|
Health Care Surveys | 2 | 2017 | 2433 | 0.040 |
Why?
|
Psychometrics | 2 | 2006 | 3062 | 0.040 |
Why?
|
Interviews as Topic | 1 | 2006 | 2741 | 0.040 |
Why?
|
Cytarabine | 1 | 2021 | 695 | 0.040 |
Why?
|
Deductibles and Coinsurance | 1 | 2001 | 315 | 0.040 |
Why?
|
Referral and Consultation | 2 | 2024 | 3619 | 0.040 |
Why?
|
Medical Assistance | 1 | 2019 | 108 | 0.040 |
Why?
|
International Agencies | 1 | 2019 | 244 | 0.040 |
Why?
|
RNA, Neoplasm | 1 | 2021 | 748 | 0.040 |
Why?
|
Washington | 1 | 1998 | 315 | 0.040 |
Why?
|
Public-Private Sector Partnerships | 1 | 2019 | 123 | 0.040 |
Why?
|
Thiazolidinediones | 1 | 2021 | 460 | 0.040 |
Why?
|
Drug Utilization | 1 | 2003 | 1190 | 0.040 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2021 | 658 | 0.040 |
Why?
|
Universities | 1 | 2022 | 1005 | 0.040 |
Why?
|
Attitude to Health | 1 | 2006 | 2024 | 0.030 |
Why?
|
Physician's Role | 1 | 2003 | 925 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2021 | 1837 | 0.030 |
Why?
|
Linear Models | 1 | 2006 | 5884 | 0.030 |
Why?
|
Gene Knockdown Techniques | 1 | 2021 | 1605 | 0.030 |
Why?
|
New York | 1 | 1998 | 882 | 0.030 |
Why?
|
Mice, SCID | 1 | 2021 | 2627 | 0.030 |
Why?
|
Health Surveys | 1 | 2005 | 4056 | 0.030 |
Why?
|
Public Health | 1 | 2009 | 2679 | 0.030 |
Why?
|
Hypertension | 1 | 2014 | 8616 | 0.030 |
Why?
|
United States | 2 | 2019 | 73027 | 0.030 |
Why?
|
Hong Kong | 1 | 2013 | 170 | 0.030 |
Why?
|
Physicians, Primary Care | 1 | 2020 | 624 | 0.030 |
Why?
|
Continuity of Patient Care | 1 | 2020 | 1078 | 0.030 |
Why?
|
Neoplastic Stem Cells | 1 | 2021 | 1351 | 0.030 |
Why?
|
Indoles | 1 | 2021 | 1835 | 0.030 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2021 | 3609 | 0.030 |
Why?
|
RNA Interference | 1 | 2021 | 2830 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2021 | 3428 | 0.020 |
Why?
|
Computer Simulation | 1 | 2004 | 6283 | 0.020 |
Why?
|
Sex Factors | 2 | 2019 | 10627 | 0.020 |
Why?
|
Retrospective Studies | 1 | 2019 | 81746 | 0.020 |
Why?
|
Salaries and Fringe Benefits | 1 | 2011 | 263 | 0.020 |
Why?
|
Cost of Illness | 1 | 2019 | 1951 | 0.020 |
Why?
|
Hematopoietic Stem Cells | 1 | 2021 | 3409 | 0.020 |
Why?
|
Age Factors | 2 | 2019 | 18407 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2001 | 12075 | 0.020 |
Why?
|
Health Behavior | 2 | 2009 | 2650 | 0.020 |
Why?
|
Demography | 1 | 2011 | 1641 | 0.020 |
Why?
|
Outpatients | 1 | 2014 | 1600 | 0.020 |
Why?
|
Logistic Models | 1 | 2020 | 13289 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2021 | 12797 | 0.020 |
Why?
|
Regression Analysis | 2 | 2006 | 6339 | 0.020 |
Why?
|
Health Transition | 1 | 2005 | 35 | 0.020 |
Why?
|
Mental Disorders | 1 | 2005 | 6875 | 0.020 |
Why?
|
Social Values | 1 | 2006 | 224 | 0.010 |
Why?
|
Cyprus | 1 | 2004 | 96 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2021 | 9536 | 0.010 |
Why?
|
Apoptosis | 1 | 2021 | 9521 | 0.010 |
Why?
|
Poverty Areas | 1 | 2006 | 268 | 0.010 |
Why?
|
Health Services for the Aged | 1 | 2007 | 264 | 0.010 |
Why?
|
Propensity Score | 1 | 2011 | 1970 | 0.010 |
Why?
|
Prospective Studies | 2 | 2020 | 54924 | 0.010 |
Why?
|
Evaluation Studies as Topic | 1 | 2005 | 1625 | 0.010 |
Why?
|
Principal Component Analysis | 1 | 2006 | 948 | 0.010 |
Why?
|
Interview, Psychological | 1 | 2005 | 811 | 0.010 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3115 | 0.010 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3238 | 0.010 |
Why?
|
Disability Evaluation | 1 | 2009 | 1835 | 0.010 |
Why?
|
Confidentiality | 1 | 2006 | 607 | 0.010 |
Why?
|
Research Design | 1 | 2017 | 6211 | 0.010 |
Why?
|
Area Under Curve | 1 | 2005 | 1642 | 0.010 |
Why?
|
Likelihood Functions | 1 | 2004 | 994 | 0.010 |
Why?
|
Insurance, Pharmaceutical Services | 1 | 2003 | 348 | 0.010 |
Why?
|
Professional-Patient Relations | 1 | 2006 | 724 | 0.010 |
Why?
|
World Health Organization | 1 | 2006 | 1328 | 0.010 |
Why?
|
Policy Making | 1 | 2003 | 546 | 0.010 |
Why?
|
Focus Groups | 1 | 2006 | 1460 | 0.010 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 1 | 2005 | 1988 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2020 | 65364 | 0.010 |
Why?
|
Choice Behavior | 1 | 2004 | 848 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2021 | 13658 | 0.010 |
Why?
|
Cohort Studies | 1 | 2020 | 41749 | 0.010 |
Why?
|
Residence Characteristics | 1 | 2007 | 2118 | 0.010 |
Why?
|
Mortality | 1 | 2007 | 2910 | 0.010 |
Why?
|
Drug Costs | 1 | 2003 | 1195 | 0.010 |
Why?
|
Quality Assurance, Health Care | 1 | 2004 | 2175 | 0.010 |
Why?
|
Mice | 1 | 2021 | 82024 | 0.010 |
Why?
|
Risk Factors | 1 | 2019 | 74936 | 0.010 |
Why?
|
Communication | 1 | 2006 | 3904 | 0.010 |
Why?
|
Databases, Factual | 1 | 2006 | 8082 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2005 | 14718 | 0.010 |
Why?
|
Animals | 1 | 2021 | 169222 | 0.000 |
Why?
|
Concepts
(270)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(23)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_